Co-creation with research participants to inform the design of electronic informed consent

Author:

De Sutter Evelien1ORCID,Geerts David2,Borry Pascal3,Coteur Kristien4ORCID,Bamps Dorien1ORCID,Marynissen Heleen1,Ampe Els5,Geenens Els5,Depré Marleen5,Huys Isabelle1

Affiliation:

1. Department of Pharmaceutical and Pharmacological Sciences, Clinical Pharmacology and Pharmacotherapy, KU Leuven, Leuven, Belgium

2. KU Leuven Digital Society Institute, KU Leuven, Leuven, Belgium

3. Department of Public Health and Primary Care, Center for Biomedical Ethics and Law, KU Leuven, Leuven, Belgium

4. Department of Public Health and Primary Care, Academic Center for General Practice, KU Leuven, Leuven, Belgium

5. Center for Clinical Pharmacology, University Hospitals Leuven, KU Leuven, Leuven, Belgium

Abstract

Objective This study aimed to provide recommendations for a personalized electronic informed consent interface that is adapted to research participants’ needs and could enable a longitudinal interaction between the participants and the research team. Methods The co-creation process consisted of three co-creation workshops, one focus group discussion, and four semi-structured interviews. In total, 24 participants, who had taken part in four disparate clinical studies in Belgium, were involved. Descriptive statistics and qualitative content analysis were applied to analyze the survey data and audio recordings. Results Varying perceptions on the type and amount of information described in an informed consent form were reported. Other findings were related to the structure and presentation of information, setting preferences for data sharing, and electronically signing new informed consent versions. Regarding the long-term interaction, most of the participants wanted to receive progress updates, including the results, of the study in which they had taken part. They proposed to receive a notification, preferably via email, in case new information is made available on the electronic informed consent interface. Conclusions To optimally support the design of an electronic informed consent interface, it is key to understand the research participants’ needs. Study findings suggest that an electronic informed consent interface may be a promising technological application to interactively provide study-related information and to keep participants informed during and after the clinical study.

Funder

euCanShare

KU Leuven

Publisher

SAGE Publications

Subject

Health Information Management,Computer Science Applications,Health Informatics,Health Policy

Reference45 articles.

1. World Health Organization. Global strategy on digital health 2020–2025, https://www.who.int/docs/default-source/documents/gs4dhdaa2a9f352b0445bafbc79ca799dce4d.pdf?sfvrsn=f112ede5_68 (2021, accessed 20 April 2022).

2. Verhenneman G. Informed consent: an ethical and legal means to empower and protect. ICRI Working paper No 14/2013 2013.

3. Personalized and long-term electronic informed consent in clinical research: stakeholder views

4. US Food and Drug Administration (FDA). Use of electronic informed consent: questions and answers. Guidance for institutional review boards, investigators, and sponsors, https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-electronic-informed-consent-clinical-investigations-questions-and-answers (2016, accessed 20 April 2022).

5. Dynamic-informed consent: A potential solution for ethical dilemmas in population sequencing initiatives

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3